Director of Investments, Life Sciences for Ben Franklin Technology Partners
Jennifer Hartt directs all of Ben Franklin’s life sciences investments in companies with technologies ranging from medical devices and diagnostics to therapeutics, and has invested in over thirty companies for Ben Franklin since arriving in 2005. Jennifer holds a Bachelor’s degree, graduating summa cum laude and Phi Beta Kappa, as well as a Master’s in Biology, both from the University of Pennsylvania. She has prior experience in lab research, clinical settings, business consulting for small and large companies, technology evaluation, licensing and equity management. Prior to joining Ben Franklin, Jennifer was Associate Director of Business Development & Equity at the University of Pennsylvania. Jennifer is involved in regional activities in technology development education and commercialization programs such as in being on a science curriculum audit committee, evaluating business plans, judging entrants in the Eastern Technology Council Enterprise Awards, mentoring students and representing her organization on the oversight committee for Coulter funding of translational research at Drexel University.